Bulls Make New Record High Despite Biotech Blues
Today's financial recap and tomorrow's financial outlook.
Express Scripts (ESRX) named AbbVie's (ABBV) Viekira Pak as its exclusive treatment for the most common form of Hepatitis C. AbbVie (ABBV) competitor Gilead (GILD), which makes more expensive competing drugs, fell 14.3% to $92.90 in reaction to the news.
This spurred concerns over additional challenges to the high prices charged by biotechnology companies, and the iShares Nasdaq Biotechnology ETF (IBB) fell 2.6% to $309.08. As of Friday's close, IBB was up 39.7% year-to-date and thus overheated, so momentum traders were quick to lock in profits.
The SPDR S&P Biotech ETF (XBI), which has a much smaller weighting in Gilead, fell 0.8%.
The action today was mixed overall.
Oil and gold were weak as the US dollar rallied, and related stock sectors were fairly weak.
Gold miners were under notable pressure and traded down towards last week's lows.
On the positive side, there was some positive momentum in economically sensitive sectors like retail, airlines, and real estate. These sectors all outperformed the S&P 500, which rose 0.4% to finish at an all-time closing high of 2078.54.
Intraday, the index reached as high as 2078.76, less than one point away from the 2079.47 all-time high.
However, the Dow Jones Industrial Average was the real star today with an 0.9% gain as major components like IBM (IBM), Boeing (BA), and Home Depot (HD) rallied.
In economics news, November Existing Home sales came in at 4.93 million vs. the 5.2 million expected. Housing stocks initially fell on the news but recovered their losses into the close. The November Chicago Fed National Activity Index was +0.73, beating the +0.25 consensus.
Tomorrow's Financial Outlook
Tuesday will be quite a busy day in terms of economic data. We'll see November Durable Goods and Q3 GDP at 8:30 a.m. ET, followed by December University of Michigan Consumer Sentiment at 9:55 a.m. Then, at 10:00 a.m., November Personal Income and Spending, PCE Prices, and New Home Sales will be released.
This is a lot of market-moving data in span of 90 minutes. Given low trading volumes because of the Christmas holiday this week, it could be a volatile morning.
Crude oil prices will also continue to drive energy stocks and by extension, the high-yield bond market.
Follow the markets all day every day with a FREE 14 day trial to Buzz & Banter. Over 30 professional traders share their ideas in real-time. Learn more.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter